ATX — Amplia Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Amplia Therapeutics, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	14.6	9.26	3.39	10.9	27.9
Net Total Receivables	1.84	1.15	3.18	3.77	4.78
Prepaid Expenses
Total Other Current Assets
Total Current Assets	16.5	10.5	6.75	14.9	33
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.013	0.185	0.101	0.017	0.354
Net Intangible Assets
Other Long Term Assets
Total Assets	24.5	18.7	14.8	22.9	41.4
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.53	2.75	3.4	1.89	1.67
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.64	2.85	3.43	1.91	1.97
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	21.8	15.8	11.4	21	39.5
Total Liabilities & Shareholders' Equity	24.5	18.7	14.8	22.9	41.4
Total Common Shares Outstanding